Why the study?
What is the global prevalence of resistant hypertension?
What is the global prevalence of resistant hypertension?
True-resistant hypertension has a high global prevalence, particularly in patients with chronic kidney disease, highlighting the critical need for ambulatory BP measurement to exclude pseudo-resistant hypertension.
Requires ambulatory BP confirmation to exclude pseudo-resistant cases; extends global prevalence estimates with highest burden in CKD.
This study shows a high prevalence of true-resistant hypertension. This prevalence is lower than that of apparent treatment-resistant hypertension, demonstrating the importance to exclude causes of pseudo-resistant hypertension including white-coat hypertension with the use of ambulatory BP measurement. The burden of resistant hypertension is highest in patients with chronic kidney disease. New treatments for resistant hypertension are highly needed, considering the disastrous complications of the disease.
No takes yet. Share an insight, caveat, or question.
Noubiap et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: